United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - dihydrocodeine tartrate - oral tablet - 30mg

Malta - English - Medicines Authority

laboratorio de aplicaciones farmacodinamicas s.a. grassot, 16, 08025, barcelona, spain - oral drops, solution - dihydrocodeine bitartrate 10 mg/ml - analgesics

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - dihydrocodeine hydrogen tartrate 60mg equivalent to dihydrocodeine 40 mg - modified release tablet - 60 mg - active: dihydrocodeine hydrogen tartrate 60mg equivalent to dihydrocodeine 40 mg excipient: cetostearyl alcohol hyetellose lactose monohydrate magnesium stearate purified talc - dhc continus is indicated for the management of severe pain where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and -the pain is opioid-responsive, and -requires daily, continuous, long term treatment. dhc continus is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. dhc continus is not indicated as an as-needed (prn) analgesia.

Ireland - English - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - dihydrocodeine hydrorhodanide - oral drops, solution - 10 milligram(s)/gram - natural opium alkaloids; dihydrocodeine

Ireland - English - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - dihydrocodeine tartrate - syrup - 0.2 percent weight/weight - natural opium alkaloids; dihydrocodeine

Ireland - English - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - dihydrocodeine hydrogen tartrate - tablet - 10 milligram(s) - natural opium alkaloids; dihydrocodeine